Hypoglycemia Management

Patient Assessment and Education

Assess changes in eating patterns and increased physical activity that may contribute to hypoglycemia in patients with diabetes, as recommended by the American Diabetes Association 1
Educate patients on treating hypoglycemia with 15-20g of fast-acting carbohydrate when blood glucose falls below a certain threshold, and checking blood glucose again after 15 minutes to ensure it has risen above that threshold, as suggested by the American Diabetes Association 1
Teach recognition of hypoglycemic symptoms, such as shakiness, irritability, confusion, tachycardia, and hunger, and instruct on proper treatment with fast-acting carbohydrates (15-20g glucose) when blood glucose falls below 70 mg/dL, as recommended by the American Diabetes Association 2, 3
Focus on preventing hypoglycemia rather than achieving tight control, to minimize hypoglycemia risk, in elderly patients, as recommended by the American Diabetes Association 4
Educate caregivers about recognition of hypoglycemia symptoms, proper carbohydrate intake, and consistent meal timing to prevent hypoglycemia in children, as recommended by the American Academy of Pediatrics 5

Hypoglycemia is classified into three levels:

Level	Blood Glucose	Description	Treatment
1	<70 mg/dL and ≥54 mg/dL	Mild hypoglycemia	15-20g oral glucose
2	<54 mg/dL	Moderate hypoglycemia	15-20g oral glucose
3	Any level	Severe event with altered mental/physical status requiring assistance	Glucagon injection	[6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17]

Administering 15-20g of glucose or any carbohydrate containing glucose can raise blood glucose, with pure glucose being preferred, according to the American Diabetes Association 18, 19, 20
Initial response to treatment should be seen within 10-20 minutes, and blood glucose should be evaluated again in 60 minutes as additional treatment may be necessary, according to the American Diabetes Association 18, 19, 20, 17

Comprehensive evaluation for suspected hypoglycemic unawareness should include assessment of hypoglycemic episodes, symptom recognition, and blood glucose patterns, followed by strict avoidance of hypoglycemia for at least several weeks to reverse the condition, as recommended by the American Diabetes Association 12
History of unexplained hypoglycemic events, especially Level 2 or Level 3, is a key factor in evaluating hypoglycemic unawareness, according to the American Diabetes Association 12
Reduced recognition of autonomic symptoms such as shakiness, irritability, confusion, tachycardia, and hunger is a characteristic of hypoglycemic unawareness, as noted by the American College of Physicians 21
Pattern of recurrent hypoglycemia despite appropriate insulin/medication dosing is an important consideration in evaluating hypoglycemic unawareness, as recommended by the American Diabetes Association 22
Raising glycemic targets to strictly avoid hypoglycemia for at least several weeks is essential to partially reverse hypoglycemia unawareness, as recommended by the American Diabetes Association 12, 22
Reevaluating and modifying the treatment regimen, including reviewing insulin/medication doses and timing, and considering insulin regimens with lower hypoglycemia risk, is crucial in managing hypoglycemic unawareness, as recommended by the American Diabetes Association 12

For neonates with hypoglycemia and neuroglycopenia, immediate IV glucose administration is preferred, with a dose of 2 mL/kg (200 mg/kg) of D10W, and ongoing management may involve continuous glucose infusion at 4-8 mg/kg/min, according to the American College of Medical Genetics and Genomics 23
For infants with Glycogen Storage Disease Type I (GSD I), continuous tube feeding may be required to maintain blood glucose levels >70 mg/dL, as recommended by the American College of Medical Genetics and Genomics 23
For suspected hypoglycemia-related emergencies, administer intravenous glucose (D10W 50mL aliquots, up to 25g total) as the first-line treatment, followed by glucagon injection if IV access is unavailable, as recommended by the American Society of Anesthesiologists and the American College of Critical Care Medicine 24, 25, 26
Hospital admission is recommended for patients with severe neuroglycopenia and altered consciousness, or if blood glucose levels are ≤50 mg/dL with no prompt recovery of sensorium after treatment, or if coma, seizures, or altered behavior are present due to documented or suspected hypoglycemia, as suggested by the American Diabetes Association 27, 28

Schedule follow-up within 1-2 weeks to review blood glucose logs and adjust medication regimen as needed, as recommended by the American College of Physicians and the American Diabetes Association 2, 4
Prescribe glucagon to all patients on insulin regimens and consider for patients taking sulfonylureas, as recommended by the American Diabetes Association 7, 12
Train family members/caregivers on glucagon administration, as recommended by the American Diabetes Association 7, 12
Consider technology solutions, such as continuous glucose monitoring with alarms and insulin pumps with low-glucose suspend features, to prevent and detect hypoglycemia 29
Avoid alcohol consumption, especially on an empty stomach, as recommended by the American Diabetes Association 12